GenEmbryomics Limited (XGEN)

GenEmbryomics will go public soon, but the exact IPO date is still unknown.

IPO Price

$4.75

Shares Offered

1,095,000

Deal Size

$5.20M

GenEmbryomics Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Net Income	-1.98	-0.52
Other Operating Activities	0.82	0.06
Operating Cash Flow	-1.17	-0.46
Share Issuance / Repurchase	0.57	0.23
Debt Issued / Paid	0.54	0.26
Financing Cash Flow	1.1	0.49
Net Cash Flow	-0.07	0.03
Free Cash Flow	-1.17	-0.46

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).